Paper Review Records
All Paper Review Records
14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
81
days
Critical roles of the long noncoding RNA SNHG4 in human cancers
Authors
Yanpin Ma; Hairui ZhouShow moreShow less
Affiliations
1. Department of Oncology, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, China; 2. Key Laboratory of Microecology-immune Regulatory Network and Related Diseases School of Basic Medicine, Jiamusi University, Jiamusi, ChinaShow moreShow less
149
days
NSUN2 regulates PARP9 progression through m5C modification to mediate breast cancer progression
Authors
Xin Li; Changjiao Yan; Jun Yi; Jun Yun; Fengqiang Cui; Xiaolong Xu; Yike Li; Xin XuShow moreShow less
Affiliations
1. Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University, Xi’an, ChinaShow moreShow less
135
days
The roles and clinical significance of LINC01140 in human cancers in the real world
Authors
Wen-Jing Men; Xiang-Sheng WenShow moreShow less
Affiliations
1. Department of Cardiothoracic Surgery, Taikang Tongji (Wuhan) Hospital, Wuhan, ChinaShow moreShow less
232
days
Transcription factor FOXA1 suppresses ferroptosis of cervical cancer cells by upregulating SLC7A11 expression
Authors
Fei Gao; Yan Zeng; Li Jia; Jun He; Huarong HeShow moreShow less
Affiliations
1. Department of Oncology, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang City, China; 2. Department of Radiology, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang City, ChinaShow moreShow less
216
days
p53 overexpression counteracts the pro-survival effect of Bcl-2 by restoring MAMs function in cutaneous squamous cell carcinoma
Authors
Yupeng Huang; Jing Liu; Xiao Shao; Chunyan Xu; Xianpeng MaShow moreShow less
Affiliations
1. Department of General Surgery, Affiliated Hospital of Beihua University, Jilin, China; 2. Department of Pharmacy, Affiliated Hospital of Beihua University, Jilin, China; 3. College of Biological and Pharmaceutical Engineering, Jilin Agricultural Science and Technology University, Jilin, China; 4. Department of Dermatology, Affiliated Hospital of Beihua University, Jilin, ChinaShow moreShow less
176
days
Esculentoside A suppresses the malignant progression of hepatocellular carcinoma by promoting RORB
Authors
Qing Ye; Dousheng Bai; Aoqing Wang; Xi Zhang; Ruiqi ChaiShow moreShow less
Affiliations
1. Department of Traditional Chinese Medicine, Subei People’s Hospital, Yangzhou, P. R. China; 2. Department of Traditional General Surgery, Subei People’s Hospital, Yangzhou, P. R. China; 3. Department of Proctology, Nanjing Hospital of Integrated Chinese and Western Medicine, Nanjing, P. R. ChinaShow moreShow less
FAQ
How long does Cell Division take to review a manuscript?
As of 2026-11-19, CrushSCI has 14 complete review records for Cell Division. The fastest paper went from submission to acceptance in 47 days (The TMPO-AS1/hsa-let-7b-5p regulatory axis shapes transcriptional heterogeneity and immune landscape in lung adenocarcinoma, received 2026-02-11, accepted 2026-03-30); the slowest took 235 days. The average is 152.3 days and the median is 155 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
